﻿<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Canada Gazette — Health</title>
    <link>http://gazette.gc.ca/rss/health-eng.xml</link>
    <description>Notices: Department of Health</description>
    <language>en-ca</language>
    <copyright>Copyright Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and Government Services, 2007</copyright>
    <pubDate>Saturday, February 04, 2012</pubDate>
    <lastBuildDate>Saturday, February 04, 2012</lastBuildDate>
    <category>Health</category>
    <generator>The Canada Gazette RSS Builder</generator>
    <item>
      <title>Food and Drug Regulations — Amendments</title>
      <link>http://gazette.gc.ca/rp-pr/p1/2012/2012-01-28/html/notice-avis-eng.html#d108</link>
      <description>DEPARTMENT OF HEALTH  - FOOD AND DRUGS ACT  - Food and Drug Regulations — Amendments  Interim Marketing Authorization  Provision currently exists in the Food and Drug Regula- tions (the Regulations) for the use of the enzyme amylase 
derived from genetically modified Bacillus amyloliquefaciens...</description>
      <pubDate>Saturday, February 04, 2012</pubDate>
    </item> 
  </channel>
</rss>
